News
Biocon Ltd. plans to file for regulatory approvals of generic versions of Novo Nordisk A/S’s Ozempic and Wegovy in key ...
The Dalai Lama said on Wednesday the institution of the Dalai Lama will continue and the Gaden Phodrang trust has sole ...
The Bengaluru-based company is seeking approval of generic Ozempic by September from Canadian authorities, and also in some ...
GLP-1 drugs currently being tested in China target complications associated with obesity such as heart disease, fatty liver ...
Eli Lilly stock currently trades below its 50-week average, offering a strong entry point despite continued dominance in ...
These popular medications are now at the center of a major weight loss drug lawsuit. Find out which drugs and involved and ...
These can include weight loss, loss of appetite, yellowing of the skin, vomiting or nausea, and the symptoms of diabetes ...
This summary covers recent developments in health from the death tied to a cyberattack on Synnovis services in the UK, the Eli Lilly and Novo Nordisk rivalry in the weight-loss drug market in India, ...
Eli Lilly and Company (NYSE:LLY) is one of the 12 stocks that will make you rich in 10 years. On June 23, Truist Securities ...
A cyberattack on Synnovis has been linked to a patient's death at King's College Hospital, marking a serious hacking ...
These six stocks span numerous sectors, providing investors with opportunities in both growth and dividend yield.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results